Skip to content
English
  • There are no suggestions because the search field is empty.

Responding to a DEA Audit

A practical guide to what happens during a DEA audit and how pharmacy staff should respond, including inspector interactions, documentation, and key steps throughout the inspection.

Related Links 

For additional resources to support DEA Readiness click HERE

FULL ARTICLE 

Overview 

The Drug Enforcement Administration (DEA) conducts audits of pharmacies to ensure compliance with federal controlled substance regulations under the Controlled Substances Act (CSA). 

These audits may occur without advance notice, making it important for pharmacy staff to understand what to expect and how to respond appropriately during an inspection. 

 

What to Expect When Inspectors Arrive 

When DEA inspectors arrive at a pharmacy, they will identify themselves and initiate the inspection process. 

During this initial interaction: 

  • Maintain a professional and courteous demeanor  
  • Verify inspector credentials  
  • Obtain business cards or contact information from each inspector  
  • Notify appropriate pharmacy leadership or compliance personnel  

Pharmacies may also choose to involve legal counsel at this stage or at any point during the audit. 

 
 

Notice of Inspection 

Inspectors will present DEA Form 82, which outlines the authority and scope of the audit. 

  • This form is typically signed by an authorized representative of the pharmacy  
  • Pharmacies have the right to refuse or withdraw consent; however, this may result in the DEA obtaining an administrative warrant to proceed  

 
 

During the Inspection 

Access and Oversight 

  • Inspectors may request access to dispensing and storage areas  
  • Pharmacy staff typically accompany inspectors throughout the audit  
  • Visitor logs may be used to document inspector access  

Documentation Review 

DEA audits commonly involve review of: 

  • Licenses and registrations  
  • Controlled substance ordering records  
  • Inventory records  
  • Prescription records  
  • Invoices and purchasing documentation  

If inspectors request original documents: 

  • Make a copy for internal records  
  • Inspectors should provide a receipt using DEA Form 12 when originals are taken  

Inspection Activities 

Inspectors may: 

  • Conduct physical inventory counts  
  • Review recordkeeping practices  
  • Ask questions about pharmacy operations and procedures  
  • Examine compliance with controlled substance regulations  

 
 

Responding to Questions 

During the audit: 

  • Provide clear and accurate answers  
  • Avoid guessing if unsure of a response  
  • It is acceptable to verify information before answering or to provide follow-up responses  

Legal counsel may be consulted when responding to questions, especially in complex situations. 

 
 

At the End of the Audit 

At the conclusion of the inspection: 

  • Inspectors may summarize their findings or observations  
  • Pharmacy staff may ask questions for clarification  
  • Any required follow-up steps or documentation requests are typically discussed  
  • Inspectors should sign out if a visitor log is maintained  

Relevant information from the audit is usually shared with pharmacy leadership and compliance personnel for further review. 

 
 

Key Takeaway 

DEA audits are a routine part of regulatory oversight. Understanding the process, maintaining organized records, and responding professionally can help ensure a smooth and compliant inspection experience. 

 

Disclaimer: These tools and templates are intended for general informational purposes and are provided by Montana Family Pharmacies as a service to pharmacies. While we try to keep the information timely and accurate, we make no guarantees. These tools and templates are not a substitute for legal, regulatory, or professional advice. 

Policies and procedure, templates, checklists, and other tools should be customized to fit the specific needs and regulatory requirements of your pharmacy. 

Montana Family Pharmacies disclaims any liability for any damages, losses, or other consequences arising from the use or reliance on the tools or policy templates.